This Article Full Text Full Text (PDF) Alert me when this article is cited Alert me if a correction is posted Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Nilsson, J. A. Articles by Cleveland, J. L. Search for Related Content PubMed PubMed Citation Articles by Nilsson, J. A. Articles by Cleveland, J. L.

Id2 Is Dispensable for Myc-Induced Lymphomagenesis

¹ Department of Biochemistry and the ² Animal Resource Center, St. Jude Children’s Research Hospital, Memphis, Tennessee, and ³ Department of Molecular Genetics, School of Medicine, University of Fukui, Fukui, Japan

The Eµ-Myc transgenic mouse appears to be an accurate model of human Burkitt’s lymphoma that bears MYC/Immunoglobulin gene translocations. Id2, a negative regulator of basic helix-loop-helix transcription factors, has also been proposed as a Myc target gene that drives the proliferative response of Myc by binding to and overriding the checkpoint functions of the retinoblastoma tumor suppressor protein. Targeted deletion of Id2 in mice results in defects in B-cell development and prevents the development of peripheral lymphoid nodes. In precancerous B cells and lymphomas that arise in Eµ-Myc transgenic mice and in Burkitt’s lymphomas, Id2 is overexpressed, suggesting that it plays a regulatory role in lymphoma development. Surprisingly, despite these connections, Eµ-Myc mice lacking Id2 succumb to lethal B-cell lymphoma at rates comparable with wild-type Eµ-Myc transgenics. Furthermore, precancerous splenic B cells lacking Id2 do not exhibit any significant defects in Myc-induced target gene transactivation and proliferation. However, due to their lack of secondary lymph nodes, Eµ-Myc mice lacking Id2 rather succumb to disseminated lymphoma with an associated leukemia, with pronounced infiltrates of the bone marrow and other major organs. Collectively these findings argue that targeting Id2 functions may be ineffective in preventing Myc-associated malignancies.

This article has been cited by other articles:

				K.-R. Wang, T. Nemoto, and Y. Yokota RFX1 Mediates the Serum-induced Immediate Early Response of Id2 Gene Expression J. Biol. Chem., September 7, 2007; 282(36): 26167 - 26177. [Abstract] [Full Text] [PDF]

				C. Renne, J. I. Martin-Subero, M. Eickernjager, M.-L. Hansmann, R. Kuppers, R. Siebert, and A. Brauninger Aberrant Expression of ID2, a Suppressor of B-Cell-Specific Gene Expression, in Hodgkin's Lymphoma Am. J. Pathol., August 1, 2006; 169(2): 655 - 664. [Abstract] [Full Text] [PDF]